The new public health chief of San Francisco has a controversial history linked to McKinsey's opioid marketing strategies, raising concerns about ethics and qualifications for addressing the ongoing opioid epidemic. Critics argue that hiring someone with such a background might hinder effective policy-making. The irony of utilizing someone who contributed to the crisis to now tackle its consequences has sparked debate among community members, highlighting skepticism about his capabilities to lead public health initiatives effectively.